{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:18:14Z","timestamp":1777537094851,"version":"3.51.4"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hereditary angioedema (HAE) is a rare heritable disorder that is characterized by recurrent, circumscribed, nonpitting, nonpruritic, often painful subepithelial swellings of sudden unpredictable onset that generally fade during 48\u201372\u2005h. Epidemiological data of hereditary angioedema patients in Belgium is lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We set up a nation-wide, multicentric study involving the 8 Belgian hospitals known to follow-up patients with Type I and II HAE. All Belgium HAE patients were asked to fill out questionnaires that mainly covered demographic data, family history, and detailed information about diagnosis, treatment and burden of their Type I and II HAE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>112 patients with type I or type II HAE could be included. Median delay between first symptoms and diagnosis was 7 years. 51% of patients had experienced pharyngeal or tongue swelling and 78% had experienced abdominal symptoms, both known to cause an important reduction in quality of life. 60% of symptomatic patients reported to receive long term prophylactic treatment. Human plasma-derived C1-esterase inhibitor concentrate was used by 56.3% of patients. 16.7% and 27.1% of patients used a 17-\u03b1-alkylated androgen and tranexamic acid as long term prophylactic therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We present the first nation-wide epidemiological study regarding HAE in Belgium. Our data show that the morbidity of HAE is not to be underestimated. Knowledge and dissemination of this data is critical in raising awareness, encouraging development of therapies and optimising nationwide management.<\/jats:p><\/jats:sec>","DOI":"10.3389\/falgy.2023.1143897","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T04:27:32Z","timestamp":1685075252000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Hereditary angioedema (HAE) in Belgium: results from a national survey"],"prefix":"10.3389","volume":"4","author":[{"given":"MM","family":"Van der Poorten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Schrijvers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bartiaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Haerynck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Lapeere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Moutschen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Sabato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DG","family":"Ebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AL","family":"Van Gasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0140-6736(11)60935-5","article-title":"Hereditary angio-oedema","volume":"379","author":"Longhurst","year":"2012","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1111\/all.15214","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema-the 2021 revision and update","volume":"77","author":"Maurer","year":"2022","journal-title":"Allergy"},{"key":"B3","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/all.13001","article-title":"International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency","volume":"72","author":"Farkas","year":"2017","journal-title":"Allergy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jaip.2017.07.002","article-title":"Hereditary angioedema in 2 sisters due to paternal gonadal mosaicism","volume":"6","author":"Ebo","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jaip.2018.10.005","article-title":"Association of hereditary angioedema type 1 with developmental anomalies due to a large and unusual de novo pericentromeric rearrangement of chromosome 11 spanning the entire C1 inhibitor gene (SERPING1)","volume":"7","author":"Ebo","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13023-020-01570-x","article-title":"Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence","volume":"15","author":"Bork","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s12016-021-08835-8","article-title":"Pathophysiology of hereditary angioedema (HAE) beyond the SERPING1 gene","volume":"60","author":"Sharma","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1081-1206(10)61121-0","article-title":"Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain","volume":"94","author":"Roche","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0131637","DOI":"10.1371\/journal.pone.0131637","article-title":"A nationwide study of Norwegian patients with hereditary angioedema with C1 inhibitor deficiency identified six novel mutations in SERPING1","volume":"10","author":"Johnsrud","year":"2015","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/j.1365-2133.2009.09366.x","article-title":"Hereditary angio-oedema in Denmark: a nationwide survey","volume":"161","author":"Bygum","year":"2009","journal-title":"Br J Dermatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"540","DOI":"10.2340\/00015555-2274","article-title":"Hereditary angioedema in Swedish adults: report from the national cohort","volume":"96","author":"Nordenfelt","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13023-015-0233-x","article-title":"A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy","volume":"10","author":"Zanichelli","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1159\/000366276","article-title":"Hereditary angioedema in Greece: the first results of the Greek hereditary angioedema registry","volume":"164","author":"Psarros","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1159\/000512933","article-title":"Acquired angioedema with C1 inhibitor deficiency: occurrence, clinical features, and management: a nationwide retrospective study in the Czech republic patients","volume":"182","author":"Sobotkova","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.22034\/iji.2020.85416.1709","article-title":"Hereditary angioedema due to C1-inhibitor deficiency in Romania: first national study, diagnostic and treatment challenges","volume":"17","author":"Gabos","year":"2020","journal-title":"Iran J Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/07853890.2018.1449959","article-title":"Hereditary angioedema due to C1-inhibitor deficiency in Macedonia: clinical characteristics, novel SERPING1 mutations and genetic factors modifying the clinical phenotype","volume":"50","author":"Griv\u010deva-Panovska","year":"2018","journal-title":"Ann Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e56712","DOI":"10.1371\/journal.pone.0056712","article-title":"Hereditary angioedema nationwide study in Slovenia reveals four novel mutations in SERPING1 gene","volume":"8","author":"Rijavec","year":"2013","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12948-021-00141-0","article-title":"Hereditary angioedema due to C1 inhibitor deficiency in Belarus: epidemiology, access to diagnosis and seven novel mutations in SERPING1 gene","volume":"19","author":"Guryanova","year":"2021","journal-title":"Clin Mol Allergy"},{"key":"B19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13223-021-00537-2","article-title":"Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report","volume":"17","author":"Bork","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.anai.2021.01.002","article-title":"Quality of life in patients with hereditary angioedema in Canada","volume":"126","author":"Lee","year":"2021","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2023.1143897\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T04:27:35Z","timestamp":1685075255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2023.1143897\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":20,"alternative-id":["10.3389\/falgy.2023.1143897"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2023.1143897","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]},"article-number":"1143897"}}